X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (2322) 2322
Publication (382) 382
Book Review (44) 44
Book / eBook (24) 24
Book Chapter (20) 20
Reference (7) 7
Dissertation (6) 6
Newsletter (6) 6
Data Set (2) 2
Conference Proceeding (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
animals (1554) 1554
index medicus (1373) 1373
neurosciences (1057) 1057
humans (734) 734
rats (682) 682
male (669) 669
mice (634) 634
brain-derived neurotrophic factor (547) 547
nervous system (540) 540
neurotrophic factor (486) 486
neurons (477) 477
brain (473) 473
brain-derived neurotrophic factor - metabolism (445) 445
bdnf (431) 431
receptor, trkb - metabolism (396) 396
research (336) 336
rodents (334) 334
rats, sprague-dawley (332) 332
signal transduction (322) 322
pharmacology & pharmacy (314) 314
female (309) 309
hippocampus (307) 307
proteins (307) 307
article (303) 303
expression (301) 301
multidisciplinary sciences (271) 271
kinases (270) 270
signal transduction - drug effects (265) 265
receptors (262) 262
long-term potentiation (261) 261
biochemistry & molecular biology (258) 258
psychiatry (255) 255
neuroscience (250) 250
cells, cultured (247) 247
physiological aspects (246) 246
neurons - metabolism (245) 245
research article (242) 242
nerve growth-factor (241) 241
phosphorylation (239) 239
cell biology (232) 232
mice, inbred c57bl (231) 231
medicine (229) 229
gene expression (226) 226
neurons - drug effects (219) 219
synaptic plasticity (210) 210
disease models, animal (209) 209
activation (205) 205
trkb receptors (204) 204
brain-derived neurotrophic factor - pharmacology (201) 201
receptor, trkb - antagonists & inhibitors (198) 198
receptor (194) 194
apoptosis (193) 193
hippocampus - metabolism (192) 192
trkb (192) 192
science (190) 190
plasticity (184) 184
health aspects (178) 178
neurology (176) 176
review (173) 173
brain-derived neurotrophic factor - genetics (172) 172
physiology (171) 171
analysis (166) 166
biology (165) 165
hippocampus - drug effects (157) 157
messenger-rna (155) 155
rats, wistar (155) 155
memory (152) 152
enzyme inhibitors - pharmacology (151) 151
antidepressants (150) 150
depression (149) 149
genetic aspects (146) 146
neurogenesis (138) 138
signal transduction - physiology (137) 137
glutamate (124) 124
dopamine (123) 123
inflammation (123) 123
receptor, trkb - genetics (122) 122
cortex (121) 121
time factors (120) 120
care and treatment (117) 117
oncology (116) 116
cancer (115) 115
carbazoles - pharmacology (115) 115
hippocampal-neurons (114) 114
clinical neurology (113) 113
mice, knockout (113) 113
in-vivo (112) 112
tyrosine (112) 112
dose-response relationship, drug (111) 111
neurons - physiology (111) 111
neuroprotection (111) 111
cell line, tumor (110) 110
glutamic acid receptors (110) 110
animal models (109) 109
neurotrophins (109) 109
brain - metabolism (108) 108
pharmacology (108) 108
stress (108) 108
brain-derived neurotrophic factor - physiology (106) 106
original (106) 106
more...
Library Location Library Location
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal of Neuroscience, ISSN 0270-6474, 08/2016, Volume 36, Issue 31, pp. 8149 - 8159
Journal Article
Journal Article
Journal Article
Journal Article
Cancer Discovery, ISSN 2159-8274, 04/2017, Volume 7, Issue 4, pp. 400 - 409
Entrectinib, a potent oral inhibitor of the tyrosine kinases TRKA/B/C, ROS1, and ALK, was evaluated in two phase I studies in patients with advanced or... 
REARRANGEMENT | ONCOGENE | ONCOLOGY | ANALOG SECRETORY CARCINOMA | LANDSCAPE | KINASE FUSIONS | SARCOMAS | ETV6-NTRK3 GENE FUSION | CRIZOTINIB | GENOMIC ALTERATIONS | CLINICAL-RESPONSE | Benzamides - pharmacokinetics | Colorectal Neoplasms - genetics | Humans | Middle Aged | Receptor, trkA - antagonists & inhibitors | Male | Receptor, trkB - genetics | Indazoles - administration & dosage | Protein Kinase Inhibitors - adverse effects | Mammary Analogue Secretory Carcinoma - genetics | Dose-Response Relationship, Drug | Benzamides - administration & dosage | Membrane Glycoproteins - antagonists & inhibitors | Receptor, trkC - genetics | Anaplastic Lymphoma Kinase | Melanoma - genetics | Colorectal Neoplasms - drug therapy | Receptor, trkB - antagonists & inhibitors | Aged, 80 and over | Receptor Protein-Tyrosine Kinases - antagonists & inhibitors | Adult | Female | Benzamides - adverse effects | Carcinoma, Non-Small-Cell Lung - pathology | Crizotinib | Protein Kinase Inhibitors - pharmacokinetics | Proto-Oncogene Proteins - antagonists & inhibitors | Pyridines - administration & dosage | Carcinoma, Non-Small-Cell Lung - genetics | Receptor, trkC - antagonists & inhibitors | Melanoma - pathology | Mammary Analogue Secretory Carcinoma - drug therapy | Membrane Glycoproteins - genetics | Protein Kinase Inhibitors - administration & dosage | Sequestosome-1 Protein - genetics | Pyrazoles - administration & dosage | Indazoles - pharmacokinetics | Receptor Protein-Tyrosine Kinases - genetics | Oncogene Proteins, Fusion - genetics | Melanoma - drug therapy | Adolescent | Receptor, trkA - genetics | Oncogene Proteins, Fusion - antagonists & inhibitors | Aged | Carcinoma, Non-Small-Cell Lung - drug therapy | Indazoles - adverse effects | Colorectal Neoplasms - pathology | Protein-Tyrosine Kinases - antagonists & inhibitors
Journal Article
International Journal of Neuropsychopharmacology, ISSN 1461-1457, 01/2014, Volume 18, Issue 4, pp. 1 - 12
Journal Article
Brain Research, ISSN 0006-8993, 2014, Volume 1577, pp. 69 - 76
Journal Article
Psychopharmacology, ISSN 0033-3158, 2/2016, Volume 233, Issue 3, pp. 405 - 415
Growing evidence suggests that downregulated clearance of glutamate and signaling pathways involving brain-derived neurotrophic factor (BDNF) and its receptor... 
Neurosciences | BDNF-TrkB signaling | Biomedicine | Ketamine | Glutamate transporter | Pharmacology/Toxicology | Psychiatry | Hippocampus | Apoptosis | NMDA RECEPTORS | PSYCHIATRY | NEUROTROPHIC FACTOR | HIPPOCAMPAL | MECHANISMS | NEUROSCIENCES | PATHOPHYSIOLOGY | FAMILY | MOOD DISORDERS | PHARMACOLOGY & PHARMACY | NEUROBIOLOGY | BRAIN | PLASTICITY | Apoptosis - drug effects | Injections, Intraventricular | Depressive Disorder - drug therapy | Male | Hippocampus - drug effects | Stress, Psychological - psychology | Excitatory Amino Acid Transporter 2 - biosynthesis | Stress, Psychological - metabolism | Receptor, trkB - antagonists & inhibitors | Behavior, Animal - drug effects | Antidepressive Agents - pharmacology | Brain-Derived Neurotrophic Factor - metabolism | Excitatory Amino Acid Transporter 2 - genetics | Astrocytes - drug effects | Rats | Excitatory Amino Acid Antagonists - pharmacology | Rats, Sprague-Dawley | Hippocampus - metabolism | Animals | Signal Transduction - drug effects | Indole Alkaloids - pharmacology | Depressive Disorder - psychology | Carbazoles - pharmacology | Ketamine - pharmacology | Chronic Disease | Receptor, trkB - metabolism | Astrocytes - metabolism | Depression, Mental | Cellular signal transduction | Dosage and administration | Glutamate | Observations | Drug therapy | Health aspects | Brain | Mental depression | Antidepressants
Journal Article
Journal of Cellular Biochemistry, ISSN 0730-2312, 09/2017, Volume 118, Issue 9, pp. 2502 - 2515
Brain‐derived neurotrophic factor (BDNF) is a potent neurotrophic factor that has been shown to stimulate breast cancer cell growth and metastasis via tyrosine... 
RISK FACTOR | PHARMACOLOGICAL MODULATORS | EPIGENETICS | BREAST CANCER | BRAIN‐DERIVED NEUROTROPHIC FACTOR | BRAIN-DERIVED NEUROTROPHIC FACTOR | WNT SIGNALING PATHWAY | TYROSINE KINASE-B | UROKINASE PLASMINOGEN-ACTIVATOR | CELLS IN-VITRO | BIOCHEMISTRY & MOLECULAR BIOLOGY | NEUROTROPHIC RECEPTOR TRKB | VAL66MET POLYMORPHISM | NEUROBLASTOMA-CELLS | MESSENGER-RNA LEVELS | CELL BIOLOGY | BDNF PROMOTER METHYLATION | ENDOTHELIAL GROWTH-FACTOR | Membrane Glycoproteins - metabolism | Humans | MicroRNAs - metabolism | Neoplasm Proteins - metabolism | RNA, Neoplasm - metabolism | Breast Neoplasms - metabolism | Breast Neoplasms - therapy | Animals | Membrane Glycoproteins - antagonists & inhibitors | RNA Interference | Breast Neoplasms - pathology | Protein Kinase Inhibitors - therapeutic use | Receptor, trkB - antagonists & inhibitors | Female | Brain-Derived Neurotrophic Factor - metabolism | Carbazoles - therapeutic use | Receptor, trkB - metabolism | Wnt Signaling Pathway | Development and progression | Breast cancer | Health aspects | Vascular endothelial growth factor | Brain | Wnt protein | Pathogenesis | Genes | Risk | AKT protein | Biochemistry | Metastasis | Metastases | β-catenin | Receptors | Cell growth | Pathways | Modulation | TrkA protein | TrkA receptors | Bioindicators | Protein-tyrosine kinase | Tyrosine | NF-κB protein | RNA-mediated interference | Mortality | Interference | Health risks | MiRNA | Gene expression | Patients | Survival | 1-Phosphatidylinositol 3-kinase | Brain-derived neurotrophic factor | Inhibitors | Ribonucleic acids | MicroRNAs | Biomarkers | Breast | Death | TrkB receptors | Aberration | Cancer
Journal Article
Behavioral Neuroscience, ISSN 0735-7044, 02/2019, Volume 133, Issue 1, pp. 32 - 38
The expression of brain derived neurotrophic factor (BDNF) and tropomyosin receptor kinase B (TrkB) are regulated by gonadal hormone signaling and are... 
brain derived neurotrophic factor | tropomyosin receptor kinase B | sexual motivation | ANA-12 | partner preference | P